Citations (16)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Yuyao Sun, Richard Bedlack, Carmel Armon, Morgan Beauchamp, Tulio Bertorini, Robert Bowser, Mark Bromberg, James Caress, Gregory Carter, Jesse Crayle, Merit E. Cudkowicz, Jonathan D. Glass, Carlayne Jackson, Isaac Lund, Sarah Martin, Sabrina Paganoni, Gary Pattee, Dylan Ratner, Kristiana Salmon & Paul Wicks. (2022) ALSUntangled #64: butyrates. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 23:7-8, pages 638-643.
Read now
Read now
Ralph Kern, Revital Aricha, Haggai Kaspi, Yael Gothelf & Chaim Lebovits. (2020) Effects of MSC-NTF cells on T and B regulatory cell function in ALS. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 21:7-8, pages 638-639.
Read now
Read now
Articles from other publishers (14)
Abdollah Jafarzadeh, Abdolkarim Sheikhi, Zahra Jafarzadeh & Maryam Nemati. (2023) Differential roles of regulatory T cells in Alzheimer's disease. Cellular Immunology 393-394, pages 104778.
Crossref
Crossref
Julia Pereira Lemos, Liliane Patrícia Gonçalves Tenório, Vincent Mouly, Gillian Butler-Browne, Daniella Arêas Mendes-da-Cruz, Wilson Savino & Piera Smeriglio. (2023) T cell biology in neuromuscular disorders: a focus on Duchenne Muscular Dystrophy and Amyotrophic Lateral Sclerosis. Frontiers in Immunology 14.
Crossref
Crossref
Swetha Ramachandran, Veselin Grozdanov, Bianca Leins, Katharina Kandler, Simon Witzel, Medhanie Mulaw, Albert C. Ludolph, Jochen H. Weishaupt & Karin M. Danzer. (2023) Low T-cell reactivity to TDP-43 peptides in ALS. Frontiers in Immunology 14.
Crossref
Crossref
Dario Gelevski, Grace Addy, Margot Rohrer, Caroline Cohen, Aimee Roderick, Allison Winter, Judith Carey, Jennifer Scalia, Megan Yerton, Harli Weber, Michael Doyle, Neil Parikh, Geli Kane, Amy Ellrodt, Katherine Burke, Derek D'Agostino, Ervin Sinani, Hong Yu, Alexander Sherman, Jan Agosti, Garry Redlich, Patrick Charmley, David Crowe, Mark Appleby, Brian Ziegelaar, Katherine Hanus, Zhenhua Li, Suma Babu, Katharine Nicholson, Sarah Luppino, James Berry, Clare Baecher‐Allan, Sabrina Paganoni & Merit Cudkowicz. (2022)
Safety and activity of
anti‐CD14
antibody
IC14
(atibuclimab) in
ALS
: Experience with expanded access protocol
. Muscle & Nerve 67:5, pages 354-362.
Crossref
Crossref
Katherine E Olson, R L Mosley & Howard E Gendelman. (2023) The potential for treg-enhancing therapies in nervous system pathologies. Clinical and Experimental Immunology 211:2, pages 108-121.
Crossref
Crossref
Kawaljit Kaur, Po-Chun Chen, Meng-Wei Ko, Sara Huerta-Yepez, Dipnarine Maharaj & Anahid Jewett. (2023) The Potential Role of Cytotoxic Immune Effectors in Amyotrophic Lateral Sclerosis (ALS); A Longitudinal Case Study Comparing Patients with Genetically Identical Healthy Twin. Critical Reviews in Immunology 43:1, pages 27-39.
Crossref
Crossref
Sean I. Savitz & Charles S. CoxJrJr. (2022) Cell-based therapies for neurological disorders — the bioreactor hypothesis. Nature Reviews Neurology 19:1, pages 9-18.
Crossref
Crossref
Solmaz Yazdani, Christina Seitz, Can Cui, Anikó Lovik, Lu Pan, Fredrik Piehl, Yudi Pawitan, Ulf Kläppe, Rayomand Press, Kristin Samuelsson, Li Yin, Trung Nghia Vu, Anne-Laure Joly, Lisa S. Westerberg, Björn Evertsson, Caroline Ingre, John Andersson & Fang Fang. (2022) T cell responses at diagnosis of amyotrophic lateral sclerosis predict disease progression. Nature Communications 13:1.
Crossref
Crossref
Minwoo Hong, Mi Jung Kang, Sehyun Pak, Ik-Hwan Han & Hyunsu Bae. (2022) Bee venom phospholipase A2 ameliorates amyotrophic lateral sclerosis by increasing regulatory T cell population. Advances in Traditional Medicine 22:3, pages 599-606.
Crossref
Crossref
Cristina Tringali & Paola Giussani. (2022) Ceramide and Sphingosine-1-Phosphate in Neurodegenerative Disorders and Their Potential Involvement in Therapy. International Journal of Molecular Sciences 23:14, pages 7806.
Crossref
Crossref
Jared S. Katzeff, Fiona Bright, Katherine Phan, Jillian J. Kril, Lars M. Ittner, Michael Kassiou, John R. Hodges, Olivier Piguet, Matthew C. Kiernan, Glenda M. Halliday & Woojin Scott Kim. (2022) Biomarker discovery and development for frontotemporal dementia and amyotrophic lateral sclerosis. Brain 145:5, pages 1598-1609.
Crossref
Crossref
Weiyi Yu, Ji He, Xiying Cai, Zhou Yu, Zhangyu Zou & Dongsheng Fan. (2022) Neuroimmune Crosstalk Between the Peripheral and the Central Immune System in Amyotrophic Lateral Sclerosis. Frontiers in Aging Neuroscience 14.
Crossref
Crossref
Orietta Pansarasa, Maria Garofalo, Eveljn Scarian, Francesca Dragoni, Jessica Garau, Rosalinda Di Gerlando, Luca Diamanti, Matteo Bordoni & Stella Gagliardi. (2022) Biomarkers in Human Peripheral Blood Mononuclear Cells: The State of the Art in Amyotrophic Lateral Sclerosis. International Journal of Molecular Sciences 23:5, pages 2580.
Crossref
Crossref
Ilaria Giovannelli, Nadhim Bayatti, Abigail Brown, Dennis Wang, Marius Mickunas, William Camu, Jean-Luc Veyrune, Christine Payan, Cecilia Garlanda, Massimo Locati, Raul Juntas-Morales, Nicolas Pageot, Andrea Malaspina, Ulf Andreasson, Carey Suehs, Safa Saker, Christophe Masseguin, John de Vos, Henrik Zetterberg, Ammar Al-Chalabi, P Nigel Leigh, Timothy Tree, Gilbert Bensimon, Paul R Heath, Pamela J Shaw & Janine Kirby. (2021) Amyotrophic lateral sclerosis transcriptomics reveals immunological effects of low-dose interleukin-2. Brain Communications 3:3.
Crossref
Crossref